Heartflow, Inc.

HTFL Healthcare Health Information Services

Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.

Revenue
+47.6%
EPS
+87.7%
Free cash flow
+62.6%

Quarter to June 2026, against a year earlier

51.74 0.21 −0.40%
Market cap
$4.5B
P/E
0.0×
Fwd P/E
−72.9×
Dividend yield
—
F-score
5/9
Altman Z
7.22
Beneish M
−2.55
Dividend safety
n/a

Heartflow, Inc. (HTFL) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Heartflow, Inc. (HTFL) trades at a P/B ratio of 16.1×. Over the past ten years it has ranged from 0.0× (September 2025) to 18.7× (October 2026); the current reading is higher than 96% of that period. That is above the Health Information Services industry median of 1.9× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 3.6× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period P/B ratio Change
Jun 2026 9.1× 24.27%
Mar 2026 7.3× 104.09%
Dec 2025 3.6× (44.97%)
Sep 2025 6.5× —
6 more quarters

Against its own ten years

Low 0.0× High 18.7×
Ten-year median 7.3×
Current reading's percentile 96

P/B ratio against peers

Company P/B ratio
TDOC Teladoc Health, Inc. compare 1.3×
OMCL Omnicell, Inc. compare 1.3×
WAY Waystar Holding Corp. compare 1.4×
PRVA Privia Health Group, Inc. compare 3.5×
HQY HealthEquity, Inc. compare 4.3×
DOCS Doximity, Inc. compare 6.4×
SDGR Schrodinger, Inc. compare 7.2×
HTFL Heartflow, Inc. 16.1×
HNGE Hinge Health Inc. compare 26.6×
Health Information Services industry median 1.9×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on HTFL